201 related articles for article (PubMed ID: 34941106)
21. Gastroduodenal Involvement in AL Amyloidosis: Case Report and Literature Review.
Ramachandran R; Grantham T; Isaac-Coss G; Etienne D; Reddy M
J Investig Med High Impact Case Rep; 2024; 12():23247096241237759. PubMed ID: 38462925
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
23. [Light chain amyloidosis].
Hegenbart U; Aus dem Siepen F; Schönland S
Inn Med (Heidelb); 2023 Sep; 64(9):842-847. PubMed ID: 37540260
[TBL] [Abstract][Full Text] [Related]
24. Macroglossia in Light-Chain Amyloidosis.
Melo Alves J; Marto N
N Engl J Med; 2018 Jun; 378(24):2321. PubMed ID: 29897852
[No Abstract] [Full Text] [Related]
25. [Motor impairment in amyloid-associated muscle pseudohypertrophy].
Komiyama A; Kijima M; Takahashi M; Ono Y; Hirayama K
Rinsho Shinkeigaku; 1991 Mar; 31(3):296-300. PubMed ID: 1893669
[TBL] [Abstract][Full Text] [Related]
26. Respiratory muscle weakness and ventilatory failure in AL amyloidosis with muscular pseudohypertrophy.
Santiago RM; Scharnhorst D; Ratkin G; Crouch EC
Am J Med; 1987 Jul; 83(1):175-8. PubMed ID: 3111259
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report.
Ono E; Ishii A; Higashi Y; Koita N; Ayaki T; Tanigaki K; Takayanagi S; Kondo N; Sakai K; Endo S; Yokoi H; Matsubara T; Minamiguchi S; Nishino I; Takahashi R; Yanagita M
BMC Nephrol; 2021 Feb; 22(1):74. PubMed ID: 33639890
[TBL] [Abstract][Full Text] [Related]
28. An interesting case of AL amyloidosis and MM: a complex scenario with cardiac involvement.
Gaba M; Kumar N; Pandey A; Dewan A
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272507
[TBL] [Abstract][Full Text] [Related]
29. Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition.
Muchtar E; Dispenzieri A; Lacy MQ; Buadi FK; Kapoor P; Hayman SR; Gonsalves W; Warsame R; Kourelis TV; Chakraborty R; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Rajkumar SV; Dingli D; Leung N; Kyle RA; Kumar SK; Gertz MA
Ann Med; 2017 Nov; 49(7):545-551. PubMed ID: 28271734
[TBL] [Abstract][Full Text] [Related]
30. Value of repeat renal biopsy in the evaluation of AL amyloidosis patients lacking renal response despite of complete hematologic remission: a case report and literature review.
Zhang P; Chen X; Zou Y; Wang W; Feng Y
BMC Nephrol; 2022 Mar; 23(1):127. PubMed ID: 35361145
[TBL] [Abstract][Full Text] [Related]
31. [AL amyloidosis, from diagnosis to treatment].
Villesuzanne C; Jaccard A; Nicol M
Rev Prat; 2020 Dec; 70(10):1137-1141. PubMed ID: 33739663
[TBL] [Abstract][Full Text] [Related]
32. Macroglossia as the first oral manifestation of dialysis-associated systemic amyloidosis.
Mohammed HF; Abdelmagied M; Jaber MA; Ingafou MS
Asian J Surg; 2023 May; 46(5):2092-2093. PubMed ID: 36428140
[No Abstract] [Full Text] [Related]
33. Myopathy in a patient with systemic AA amyloidosis possibly induced by psoriasis vulgaris: An autopsy case.
Tanabe H; Maki Y; Urabe S; Higuchi I; Obayashi K; Hokezu Y
Muscle Nerve; 2015 Dec; 52(6):1113-7. PubMed ID: 26179325
[TBL] [Abstract][Full Text] [Related]
34. Skeletal muscle pseudohypertrophy in primary amyloidosis.
Whitaker JN; Hashimoto K; Quinones M
Neurology; 1977 Jan; 27(1):47-54. PubMed ID: 189252
[TBL] [Abstract][Full Text] [Related]
35. Coexistence of amyloidosis and light chain deposition disease in the heart.
Sobue Y; Takemura G; Kawamura S; Yano T; Kanamori H; Morimoto SI; Matsuo H
Cardiovasc Pathol; 2021; 51():107315. PubMed ID: 33264681
[TBL] [Abstract][Full Text] [Related]
36. Successful Treatment of Systemic Light Chain Amyloidosis with Liver Involvement using Low-Frequency Daratumumab: A Case Report.
Meng X; He J; Cheng F; Yan H; Zhu C; Guo X; Li Y; Cai Z; He D
Am J Case Rep; 2024 Jan; 25():e942534. PubMed ID: 38229422
[TBL] [Abstract][Full Text] [Related]
37. Amyloidosis: review of 236 cases.
Kyle RA; Bayrd ED
Medicine (Baltimore); 1975 Jul; 54(4):271-99. PubMed ID: 1152671
[TBL] [Abstract][Full Text] [Related]
38. 'Valvular' AL amyloidosis.
Jozsa C; Lloyd G; Bhattacharyya S
Eur Heart J; 2019 Dec; 40(45):3717. PubMed ID: 31364714
[No Abstract] [Full Text] [Related]
39. [Periorbital purpura: a pathognomonic but late sign of AL amyloidosis].
Visconti L; Cernaro V; Ferrara D; Lacava V; Ricciardi CA; Di Mauro E; Amico L; Santoro D; Buemi M
G Ital Nefrol; 2015; 32(5):. PubMed ID: 26480258
[TBL] [Abstract][Full Text] [Related]
40. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release.
Sperry BW; Reyes BA; Ikram A; Donnelly JP; Phelan D; Jaber WA; Shapiro D; Evans PJ; Maschke S; Kilpatrick SE; Tan CD; Rodriguez ER; Monteiro C; Tang WHW; Kelly JW; Seitz WH; Hanna M
J Am Coll Cardiol; 2018 Oct; 72(17):2040-2050. PubMed ID: 30336828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
